Kaleido
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kaleido - overview
Established
2013
Location
Utrecht, -, Netherlands
Primary Industry
Medical Devices & Equipment
About
Founded in 2013 and based in Utrecht, Netherlands, the current CEO is Frans Cromme, and the founder, Tim Oakes, ViCentra B. V. , trading under the name Kaleido an insulin delivery solution aimed at individuals with diabetes. The Kaleido Insulin Pump features customizability with various colors and integrates with the DBLG1 algorithm and Dexcom G6 monitoring system for real-time adjustments.
In January 2026, Kaleido raised USD 13 million in series D funding from new investors ROM Utrecht Region, Venturing Tech, with participation from returning investor Innovation Industries. Other unspecified investors also participated in the round. ViCentra B. V.
developed Kaleido, an insulin delivery solution aimed at individuals with diabetes. The Kaleido Insulin Pump features customizability with various colors and integrates with the DBLG1 algorithm and Dexcom G6 monitoring system for real-time adjustments. Currently, these products are primarily available in Germany and the Netherlands, catering to adults with diabetes and their healthcare providers while prioritizing ease of use and sustainability. In 2023, ViCentra B.
V. reported a revenue of EUR 1,503,364 with an EBITDA of EUR -10,266,035, generated mainly from the sales of its insulin pumps and consumables, including a Starter Kit offering two pumps with a four-year warranty. The company will use the January 2026 funding to support the further enhancement of its manufacturing capabilities and expansion plans initiatives.
Current Investors
EQT Life Sciences, Inkef, Health Innovations
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Medical Supplies, Monitoring Equipment
Website
www.hellokaleido.com
Verticals
HealthTech, Manufacturing, Mobile Apps, Wearables & Quantified Self
Company Stage
Series D
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.